Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Lucid Has Lost Its Luster, But It’s Still Too Early to Buy

By Thomas Niel, InvestorPlace Contributor

As there remains a strong chance LCID stock returns to its original SPAC price before it bottoms out, take your time before buying.

Expect More Disappointment With Nio Stock

By Thomas Niel, InvestorPlace Contributor

China's latest Covid-19 outbreak may not be a "game over" moment,  but its impact may not yet be fully reflected in the price of NIO stock.

Gogoro Stock Is Worth a Look Following Its Post-Debut Slump

By Thomas Niel, InvestorPlace Contributor

GGR stock has dropped over 60% since the closing of the SPAC merger that took it public. This puts Gogoro in an interesting situation.

There’s Little Reason to Hold GameStop Stock Going Into the Summer

By Thomas Niel, InvestorPlace Contributor

The meme stock legend's earning report, set for release in June, could determine how GME stock performs this summer.

Little Downside, but Little Upside, With Aurora Cannabis Stock

By Thomas Niel, InvestorPlace Contributor

While projected cost savings are a promising sign, it's not something that will grow the current valuation of ACB stock.

Quantumscape Is Still Making Progress, Still Too Early to Buy

By Thomas Niel, InvestorPlace Contributor

With its revenues not expected to really take off until 2026 and 2027, you could be sitting underwater for quite some time. With this in mind, there's more downside risk than upside potential in buying QS stock at present.

All Bets Are Off Whether Clover Health Stock Surges or Sinks From Here

By Thomas Niel, InvestorPlace Contributor

It's not for certain CLOV stock spikes after its upcoming earnings report, and a lot needs to happen for it to make a true price recovery.

Ripple’s Problems are in America, but its Future is Overseas

By Thomas Niel, InvestorPlace Contributor

Even if the gains come in a gradual pace, it may be worthwhile to consider XRP as a long-term investment, due to a catalyst related to its main use case, not from the Ripple vs. SEC verdict.

SoFi Stock Offers a Lot of Waiting for Not Much Upside

By Thomas Niel, InvestorPlace Contributor

Given the time it'll take for this fintech supermarket to reach profitability, there's little appeal with SOFI stock at today's prices.

7 Long-Term Stocks to Buy for a Robust Retirement

By Thomas Niel, InvestorPlace Contributor

The amount of years you spend in retirement may vary, yet it's not a bad idea to err on the side of caution. That is, you should build a portfolio that can grow and provide income for 15, 20, perhaps even 30 years. Adding names like these 7 long-term stocks to buy may be the way to achieve this:

Load More